Prostate Cancer

Show: All Sections A Piece of My Mind Book and Media Reviews Brief Reports Capitol Health Call Care of the Aging Patient Caring for the Critically Ill Patient Clinical Crossroads Clinical Reviews Commentaries Controversies Editorials From the Archives Journals: Abstracts and Commentary From the Centers for Disease Control and Prevention Grand Rounds Health Law and Ethics JAMA Classics JAMA Patient Page Letters Literatim Medical News & Perspectives News and Analysis On Call Original Contributions Perspectives on Care at the Close of Life Poetry and Medicine Preliminary Communications Research Letters Reviews Special Communications The Cover The Patient-Physician Relationship The Rational Clinical Examination This Week in JAMA Users' Guides to the Medical Literature

Displaying results 1-10 of 184

Most recent content (February 1, 2012):

• Letters:

  Prostate Cancer Risk and Vitamin E

  • Alan R. Gaby

  JAMA. 2012;307(5):453-454.doi:10.1001/jama.2012.54
  • Extract
  • Full Text
  • Full Text (PDF)
• Letters:

  Prostate Cancer Risk and Vitamin E—Reply

  • Eric A. Klein

  JAMA. 2012;307(5):454doi:10.1001/jama.2012.56
  • Extract
  • Full Text
  • Full Text (PDF)
• Letters:

  Prostate Cancer Risk and Vitamin E

  • Sumedh S. Hoskote,
  • Girish N. Nadkarni,
  • Ethan D. Fried

  JAMA. 2012;307(5):454doi:10.1001/jama.2012.55
  • Extract
  • Full Text
  • Full Text (PDF)

Past content (since May 1998):

• Research Letters:

  Screening for Osteoporosis in Men Receiving Androgen Deprivation Therapy

  • Shabbir M. H. Alibhai,
  • Lingsong Yun,
  • Angela M. Cheung,
  • Lawrence Paszat

  JAMA. 2012;307(3):255-256.doi:10.1001/jama.2011.2022
  • Extract
  • Full Text
  • Full Text (PDF)
• Medical News & Perspectives:

  Expert Panel Advocates Surveillance for Men With Low-Risk Prostate Cancer

  • Anita Slomski

  JAMA. 2012;307(2):133doi:10.1001/jama.2011.1965
  • Extract
  • Full Text
  • Full Text (PDF)
• Commentaries:

  Grading the New US Preventive Services Task Force Prostate Cancer Screening Recommendation

  • Robert J. Volk,
  • Andrew M. D. Wolf

  JAMA. 2011;306(24):2715-2716.doi:10.1001/jama.2011.1893
  • Extract
  • Full Text
  • Full Text (PDF)
• Commentaries:

  Prostate Cancer Screening—Time to Abandon One-Size-Fits-All Approach?

  • Jeri Kim,
  • John W. Davis

  JAMA. 2011;306(24):2717-2718.doi:10.1001/jama.2011.1881
  • Extract
  • Full Text
  • Full Text (PDF)
• Commentaries:

  Missing the Mark on Prostate-Specific Antigen Screening

  • David C. Miller,
  • Brent K. Hollenbeck

  JAMA. 2011;306(24):2719-2720.doi:10.1001/jama.2011.1879
  • Extract
  • Full Text
  • Full Text (PDF)
• Commentaries:

  Prostate Cancer Screening—The Evidence, the Recommendations, and the Clinical Implications

  • Roger Chou,
  • Michael L. LeFevre

  JAMA. 2011;306(24):2721-2722.doi:10.1001/jama.2011.1891
  • Extract
  • Full Text
  • Full Text (PDF)
  • Author Interview
• Medical News & Perspectives:

  USPSTF Finds Little Evidence to Support Advising PSA Screening in Any Man

  • Anita Slomski

  JAMA. 2011;306(23):2549-2551.doi:10.1001/jama.2011.1804
  • Extract
  • Full Text
  • Full Text (PDF)